NL1013750C1 - Nieuwe samenstelling. - Google Patents

Nieuwe samenstelling. Download PDF

Info

Publication number
NL1013750C1
NL1013750C1 NL1013750A NL1013750A NL1013750C1 NL 1013750 C1 NL1013750 C1 NL 1013750C1 NL 1013750 A NL1013750 A NL 1013750A NL 1013750 A NL1013750 A NL 1013750A NL 1013750 C1 NL1013750 C1 NL 1013750C1
Authority
NL
Netherlands
Prior art keywords
composition
diluent
weight
water
soluble
Prior art date
Application number
NL1013750A
Other languages
English (en)
Dutch (nl)
Inventor
David Philip Elder
Meneaud Padma Patel
Ahmad Khalaf Al Deeb A Ghazawi
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of NL1013750C1 publication Critical patent/NL1013750C1/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL1013750A 1999-06-22 1999-12-03 Nieuwe samenstelling. NL1013750C1 (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9914601 1999-06-22
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GB9914709 1999-06-23
GB9927501 1999-11-19
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (1)

Publication Number Publication Date
NL1013750C1 true NL1013750C1 (nl) 2000-12-28

Family

ID=27269749

Family Applications (2)

Application Number Title Priority Date Filing Date
NL1013750A NL1013750C1 (nl) 1999-06-22 1999-12-03 Nieuwe samenstelling.
NL1013749A NL1013749C2 (nl) 1999-06-22 1999-12-03 Nieuwe samenstelling.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL1013749A NL1013749C2 (nl) 1999-06-22 1999-12-03 Nieuwe samenstelling.

Country Status (21)

Country Link
EP (1) EP1064936A1 (fr)
AT (1) AT3722U1 (fr)
AU (2) AU727000B3 (fr)
BE (2) BE1013166A6 (fr)
CA (1) CA2291542A1 (fr)
CH (1) CH690024A5 (fr)
DE (2) DE19958228A1 (fr)
DK (2) DK199900435U3 (fr)
ES (1) ES2159260B1 (fr)
FI (2) FI4488U1 (fr)
FR (1) FR2795327A1 (fr)
GB (1) GB2351233A (fr)
GR (1) GR1003490B (fr)
IE (2) IE991107A1 (fr)
IT (1) ITMI992549A1 (fr)
LU (1) LU90483B1 (fr)
NL (2) NL1013750C1 (fr)
NO (1) NO995945L (fr)
PT (1) PT102384A (fr)
SE (1) SE9904404L (fr)
WO (1) WO2000078291A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6645523B2 (en) * 2000-08-28 2003-11-11 Synthon Bct Technologies, Llc Paroxetine compositions and processes for making the same
AU2001284322A1 (en) 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (fr) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquide pour administration orale contenant de la paroxetine
MXPA04007428A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
EP1660496A1 (fr) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Procede pour la synthese de zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558679A1 (fr) * 1990-11-24 1993-09-08 BEECHAM GROUP plc Utilisation de paroxetine pour le traitement de la demence senile, la boulimie, la migraine ou l'anorexie
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
ES2155995T3 (es) * 1997-06-10 2001-06-01 Synthon Bv Compuestos de 4-fenilpiperidina.
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
WO2000078291A1 (fr) 2000-12-28
GR1003490B (el) 2000-11-30
SE9904404D0 (sv) 1999-12-03
BE1012806A3 (fr) 2001-03-06
IES991108A2 (en) 2001-04-04
DE19958228A1 (de) 2000-12-28
FI19992609A (fi) 2000-12-22
FIU990494U0 (fi) 1999-12-03
FR2795327A1 (fr) 2000-12-29
DE29921300U1 (de) 2000-02-10
ITMI992549A1 (it) 2001-06-03
CH690024A5 (fr) 2000-03-31
IE991107A1 (en) 2001-05-30
NO995945L (no) 2000-12-27
GB2351233A (en) 2000-12-27
CA2291542A1 (fr) 2000-12-22
EP1064936A1 (fr) 2001-01-03
SE9904404L (sv) 2000-12-23
AU1573100A (en) 2001-01-09
LU90483B1 (fr) 2001-01-31
AT3722U1 (de) 2000-07-25
BE1013166A6 (fr) 2001-10-02
ITMI992549A0 (it) 1999-12-03
FI4488U1 (fi) 2000-07-20
ES2159260A1 (es) 2001-09-16
DK199901730A (da) 2000-12-23
ES2159260B1 (es) 2002-05-01
DK199900435U3 (da) 2000-02-11
NL1013749C2 (nl) 2001-01-08
AU727000B3 (en) 2000-11-30
NO995945D0 (no) 1999-12-03
PT102384A (pt) 2000-12-29
GB9928673D0 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
JP3589977B2 (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
CA2321523C (fr) Procede utilisant des super-desintegrants dans la preparation de capsules ou de comprimes d'efavirenz a dissolution rapide
PL201409B1 (pl) Kompozycja farmaceutyczna zawierająca celekoksyb
NO170753B (no) Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering
EP2331074A1 (fr) Granulés, leur procédé de préparation et produits pharmaceutiques les contenant
CZ20022140A3 (cs) Formulace inhibitoru cyklooxygenázy -2 s postupným uvolňováním
WO2005084648A1 (fr) Compositions pharmaceutiques comprenant du candesartan cilexetil
EP4076402A1 (fr) Forme posologique comprenant une solution solide amorphe d'empagliflozine avec un polymère
NL1013750C1 (nl) Nieuwe samenstelling.
JP2006328000A (ja) 経口投与用製剤
HU231036B1 (hu) Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény
EP2590652A1 (fr) Compositions pharmaceutiques contenant de la vanoxérine
EP1865927A1 (fr) Preparation de topiramate sous forme de comprime
JP2006527260A (ja) 湿式顆粒化で調製されたアトルバスタチンの安定な組成物
KR20110085307A (ko) 난용성 약물을 함유하는 경구 제형
CN105407876B (zh) 抗结核病的稳定的包含异烟肼颗粒和利福喷汀颗粒的可分散的片剂及其制备方法
WO2000078290A2 (fr) Nouvelle preparation
WO2019170244A1 (fr) Formulation de comprimé contenant du ticagrelor
WO2019008426A1 (fr) Nouvelle composition de forme galénique orale d'enzalutamide et procédé de fabrication de celle-ci
KR102286500B1 (ko) 레날리도마이드를 포함하는 경구용 고형제제의 제조방법
EP2391350A1 (fr) Préparations d'atazanavir
AU6307299A (en) Novel composition
CA2709624A1 (fr) Forme posologique a liberation immediate de bosentan et procede de fabrication de ladite forme posologique
WO2010062996A2 (fr) Composition de ribavirine
WO2005030201A1 (fr) Preparation a liberation prolongee contenant de l'hydrochlorothiazide et du carvedilol/atenolol

Legal Events

Date Code Title Description
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20040701